IE
NMRD

Israel Englander’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Israel Englander’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-62,908
Closed -$651K – 7404
2021
Q2 		$651K Buy
+62,908
New +$601K ﹤0.01% 5071

Other funds holding NMRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Israel Englander's NMRD Position: Q3 2021 in Review

Israel Englander sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q3 2021, closing a stake of 62,908 shares — an estimated $651K sold.

Israel Englander first reported a position in NMRD in Q2 2021 and held it in 1 quarter. The position peaked at $651K in Q2 2021. 17 funds tracked by Wall St. Rank hold NMRD as of Q3 2021.

  • Israel Englander reported no remaining Nemaura Medical, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Israel Englander sold 62,908 Nemaura Medical, Inc. Common Stock shares in Q3 2021, an estimated $651K.
  • Israel Englander first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Israel Englander's Nemaura Medical, Inc. Common Stock position peaked at $651K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q3 2021.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.